A. Jeziorski et al., The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast, J EXP CL C, 19(1), 2000, pp. 61-67
Citations number
40
Categorie Soggetti
Oncology
Journal title
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
The aim of the study was to examine the consecutive series of primary ducta
l invasive tumours and find out: a) the expression of some biological cellu
lar parameters as proliferating antigens Ki67 and PCNA and products of gene
EGFR, erbB2; b) correlation between the levels of expression of those fact
ors and classical prognostic factors, such as diameter of tumour, status of
axillary lymph nodes, status of steroids receptors, the degree of histolog
ical differentiation. We found that: I. The presence of the expression of o
ncoproteins c-erbB2 and EGFR, high index IP PCNA, Ki67 and low levels of st
eroids receptors correlates with high histological malignancy (Bloom III de
grees); 2. The lack of expression of oncoproteins c-erbB2, EGFR and low ind
ex IP PCNA, Ki67 correlates with high levels of steroids receptors; 3. The
estimation of high levels of index IP PCNA, IP Ki67 can be helpful for sepa
rate tumours of high proliferating activity; 4. The expression of oncoprote
in c-erbB2 and EGFR does not correlate with the diameter of tumour as well
as with the involvement of axillary lymph nodes.
It seems that the estimation of proliferating antigens together with the ex
pression of oncoproteins might have greater prognostic value than the estim
ation of one of these factors.